News
An experimental new treatment is showing early promise in the fight against liver fibrosis – a serious and often silent ...
Liver disease is a modifiable cardiac risk factor, and this study confirmed that it can be quantified with MRI iron corrected ...
FOX 7 Austin on MSN4h
Semaglutides: Benefits for liver disease patientsIt's a key component of weight lost and diabetes drugs and researchers have found it can do wonders for those who have ...
Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...
14h
GlobalData on MSNRoche introduces diagnostic test for liver fibrosis severity assessmentRoche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...
To advance the understanding and treatment of liver disease by pursuing innovative, transformative basic and translational ...
An experimental new treatment is showing early promise in the fight against liver fibrosis - a serious and often silent condition that affects around ...
VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a commercial ...
Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when ...
Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...
Roche launches innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity: Basel Wednesday, May 7, 2025, 10:00 Hrs [IST] Roche announced the launch ...
She wrote that she lost her brother at a time when she is yet to come to terms with her parents' death..vishuprasad death, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results